Public report overview
Executive summary and expectations
This public page contains a limited overview. Detailed drivers, macro context, management guidance, market reaction, and the full analysis remain in GoAI. Consensus estimates may change before the release; the cards above show the latest available figures, while the report reflects its generation-time snapshot.
Pre-Earnings Preview: Salesforce, Inc. (CRM) — Q2 FY27
TL;DR
- Date & Time: Confirmed for August 26, 2026, after market close.
- Fiscal Quarter: Q2 FY27.
- Consensus Estimates: Non-GAAP EPS of $3.27; Revenue of $11.33B.
- Implied Move: Options market pricing ±8.03% event move.
- Single Biggest Swing Factor: Commercial traction and net-ACV contribution of Agentforce AI deployments versus renewal friction in legacy software units (Tableau/Marketing Cloud).
Setup Overview
Salesforce enters its Q2 FY27 report with consensus projecting EPS of $3.27 (+10.5% Y/Y implied) and revenue of $11.33B (+10.5% Y/Y growth at midpoint), sitting squarely inside management's guidance range of $11.27B–$11.35B. Earnings estimate revisions heading into the release have remained stable.
Sector read-throughs present a bifurcated backdrop. Enterprise cloud infrastructure (MSFT Azure +45% CC) and automated workflow software (ServiceNow subscription +24% Y/Y, AI bookings +40% QoQ) demonstrate strong enterprise IT spend. Conversely, traditional seat-based SaaS peers (Workday, Atlassian) face valuation compression over generative AI substitution concerns. Wall Street sentiment on Salesforce remains moderately bullish (24 Buys, 18 Holds, 3 Sells; average 12-month PT $249.87), underpinned by expectations for second-half core business acceleration.
Historical Pattern
Salesforce holds a perfect earnings beat record over the last 8 quarters, topping non-GAAP EPS estimates in every period. However, historical post-earnings price reactions reflect asymmetric sensitivity to forward outlook rather than headline beats:
- Q1 FY27: Beat estimates; stock moved -1.62%.
- Q4 FY26: Beat estimates; stock gained +7.58%.
- Q3 FY26: Beat estimates; stock gained +5.43%.
- Q2 FY26: Beat estimates; stock moved -3.50%.
- Q1 FY26: Beat estimates; stock gained +3.20%.
- Q4 FY25: Beat estimates; stock gained +4.10%.
- Q3 FY25: Beat estimates; stock surged +11.00%.
- Q2 FY25: Beat estimates; stock moved -0.70%.
In Q1 FY27, management raised full-year FY27 targets to $45.9B–$46.2B in revenue and $14.06–$14.12 in non-GAAP EPS, establishing a high bar for guidance execution.